首页> 美国卫生研究院文献>Antimicrobial Agents and Chemotherapy >Metronidazole and Hydroxymetronidazole Central Nervous System Distribution: 2. Cerebrospinal Fluid Concentration Measurements in Patients with External Ventricular Drain
【2h】

Metronidazole and Hydroxymetronidazole Central Nervous System Distribution: 2. Cerebrospinal Fluid Concentration Measurements in Patients with External Ventricular Drain

机译:甲硝唑和羟甲硝唑中枢神经系统分布:2.外室引流患者的脑脊液浓度测量

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

This study explored metronidazole and hydroxymetronidazole distribution in the cerebrospinal fluid (CSF) of brain-injured patients. Four brain-injured patients with external ventricular drain received 500 mg of metronidazole over 0.5 h every 8 h. CSF and blood samples were collected at steady state over 8 h, and the metronidazole and hydroxymetronidazole concentrations were assayed by high-pressure liquid chromatograph. A noncompartmental analysis was performed. Metronidazole is distributed extensively within CSF, with a mean CSF to unbound plasma AUC0–τ ratio of 86% ± 16%. However, the concentration profiles in CSF were mostly flat compared to the plasma profiles. Hydroxymetronidazole concentrations were much lower than those of metronidazole both in plasma and in CSF, with a corresponding CSF/unbound plasma AUC0–τ ratio of 79% ± 16%. We describe here for the first time in detail the pharmacokinetics of metronidazole and hydroxymetronidazole in CSF.
机译:这项研究探讨了甲硝唑和羟甲硝唑在脑损伤患者脑脊液(CSF)中的分布。 4名脑外引流的脑损伤患者每8小时在0.5小时内接受500毫克甲硝唑。在超过8小时的稳定状态下收集CSF和血液样本,并通过高压液相色谱法测定甲硝唑和羟甲硝唑的浓度。进行非房室分析。甲硝唑在脑脊液中广泛分布,平均脑脊液与未结合血浆的AUC0-τ比率为86%±16%。但是,CSF中的浓度曲线与血浆曲线相比基本持平。血浆和脑脊液中羟甲硝唑的浓度均远低于甲硝唑,相应的脑脊液/未结合血浆的AUC0-τ比率为79%±16%。我们在这里首次详细描述了甲硝唑和羟甲硝唑在脑脊液中的药代动力学。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号